About us

What we do

Pharmaceuticals with a difference

With a guiding principle of working to improve your health, we deliver pharmaceuticals that make a real difference to people’s health.

AFT is a growing multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories. Our diverse range of products includes both proprietary and in-licensed items, which are available in more than 85 countries worldwide.

We continue to invest in extending our global reach, expanding our product range, and adding new medicines to a research and development portfolio that promises better health outcomes for people around the world.

AFT Pharmaceuticals SA (Pty) Ltd (‘AFT SA’) was established in early 2025 as part of our global expansion strategy. Jointly owned by AFT Pharmaceuticals (70%) and Edge Pharmaceuticals (30%), AFT SA is able to leverage both companies’ pharmaceutical products as well as Edge’s international expertise in accessing markets.

Following its acquisition of the Hospital Division business of Pharma Dynamics (Pty) Ltd in October 2025, AFT SA now holds a SAHPRA[1] licence and offers a portfolio of more than 30 trusted hospital products. From 2026 onward, it will expand access to a growing range of globally marketed therapeutics for South African hospitals and the wider community.

More about our history here